Beata Peplonska

Author PubWeight™ 123.44‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 2007 29.23
2 A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nat Genet 2009 8.39
3 A common coding variant in CASP8 is associated with breast cancer risk. Nat Genet 2007 7.35
4 Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nat Genet 2009 7.30
5 Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics. PLoS Genet 2008 6.22
6 Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst 2010 4.54
7 Differences in risk factors for breast cancer molecular subtypes in a population-based study. Cancer Epidemiol Biomarkers Prev 2007 4.23
8 Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet 2012 3.69
9 Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium. Hum Mol Genet 2011 2.72
10 Tobacco smoking, NAT2 acetylation genotype and breast cancer risk. Int J Cancer 2006 2.31
11 Polymorphisms in DNA double-strand break repair genes and risk of breast cancer: two population-based studies in USA and Poland, and meta-analyses. Hum Genet 2006 2.02
12 Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancer. Cancer Res 2007 1.92
13 Considerations of circadian impact for defining 'shift work' in cancer studies: IARC Working Group Report. Occup Environ Med 2010 1.60
14 Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer. Cancer Res 2009 1.59
15 Endometrial cancer and genetic variation in PTEN, PIK3CA, AKT1, MLH1, and MSH2 within a population-based case-control study. Gynecol Oncol 2010 1.47
16 Genetic polymorphisms in base-excision repair pathway genes and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 2006 1.34
17 Variation in breast cancer hormone receptor and HER2 levels by etiologic factors: a population-based analysis. Int J Cancer 2007 1.31
18 Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev 2009 1.29
19 Estimating age-specific breast cancer risks: a descriptive tool to identify age interactions. Cancer Causes Control 2007 1.28
20 Genetic polymorphisms in the one-carbon metabolism pathway and breast cancer risk: a population-based case-control study and meta-analyses. Int J Cancer 2007 1.28
21 Ovarian cancer risk and common variation in the sex hormone-binding globulin gene: a population-based case-control study. BMC Cancer 2007 1.27
22 Common breast cancer susceptibility variants in LSP1 and RAD51L1 are associated with mammographic density measures that predict breast cancer risk. Cancer Epidemiol Biomarkers Prev 2012 1.26
23 Hormonal markers in breast cancer: coexpression, relationship with pathologic characteristics, and risk factor associations in a population-based study. Cancer Res 2007 1.22
24 Expression of TGF-beta signaling factors in invasive breast cancers: relationships with age at diagnosis and tumor characteristics. Breast Cancer Res Treat 2009 1.20
25 Analysis of terminal duct lobular unit involution in luminal A and basal breast cancers. Breast Cancer Res 2012 1.16
26 Common genetic variation in TP53 and its flanking genes, WDR79 and ATP1B2, and susceptibility to breast cancer. Int J Cancer 2007 1.12
27 Genetic variation in tumor necrosis factor and lymphotoxin-alpha (TNF-LTA) and breast cancer risk. Hum Genet 2007 1.10
28 Genetic variation in CYP17 and endometrial cancer risk. Hum Genet 2008 1.09
29 The ATM missense mutation p.Ser49Cys (c.146C>G) and the risk of breast cancer. Hum Mutat 2006 1.09
30 Common genetic variation in the sex hormone metabolic pathway and endometrial cancer risk: pathway-based evaluation of candidate genes. Carcinogenesis 2010 1.07
31 DNA hypermethylation of ESR1 and PGR in breast cancer: pathologic and epidemiologic associations. Cancer Epidemiol Biomarkers Prev 2009 1.04
32 Genetic variation in SIPA1 in relation to breast cancer risk and survival after breast cancer diagnosis. Int J Cancer 2009 0.98
33 Common genetic variation in GATA-binding protein 3 and differential susceptibility to breast cancer by estrogen receptor alpha tumor status. Cancer Epidemiol Biomarkers Prev 2007 0.94
34 Genetic variation of Cytochrome P450 1B1 (CYP1B1) and risk of breast cancer among Polish women. Pharmacogenet Genomics 2006 0.93
35 Intrauterine environment and breast cancer risk in a population-based case-control study in Poland. Int J Cancer 2006 0.89
36 Accelerometer-based measures of active and sedentary behavior in relation to breast cancer risk. Breast Cancer Res Treat 2012 0.89
37 Comprehensive assessment of genetic variation of catechol-O-methyltransferase and breast cancer risk. Cancer Res 2006 0.89
38 Active and passive cigarette smoking and the risk of endometrial cancer in Poland. Eur J Cancer 2009 0.87
39 Intake of fruits, and vegetables in relation to breast cancer risk by hormone receptor status. Breast Cancer Res Treat 2007 0.87
40 No association between FTO or HHEX and endometrial cancer risk. Cancer Epidemiol Biomarkers Prev 2010 0.87
41 Analysis of serum metabolic profiles in women with endometrial cancer and controls in a population-based case-control study. J Clin Endocrinol Metab 2012 0.85
42 Genetic variation in PRL and PRLR, and relationships with serum prolactin levels and breast cancer risk: results from a population-based case-control study in Poland. Breast Cancer Res 2011 0.83
43 Field comparison of inhalable aerosol samplers applied in the european rubber manufacturing industry. Int Arch Occup Environ Health 2006 0.83
44 Earlier onset of Alzheimer's disease: risk polymorphisms within PRNP, PRND, CYP46, and APOE genes. J Alzheimers Dis 2009 0.83
45 Estrogen receptor and progesterone receptor expression in normal terminal duct lobular units surrounding invasive breast cancer. Breast Cancer Res Treat 2012 0.81
46 Plasma carotenoid- and retinol-weighted multi-SNP scores and risk of breast cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. Cancer Epidemiol Biomarkers Prev 2013 0.81
47 CYP46: a risk factor for Alzheimer's disease or a coincidence? Neurosci Lett 2005 0.81
48 HSD17B1 genetic variants and hormone receptor-defined breast cancer. Cancer Epidemiol Biomarkers Prev 2008 0.80
49 Cancer mortality and occupational exposure to aromatic amines and inhalable aerosols in rubber tire manufacturing in Poland. Cancer Epidemiol 2009 0.79
50 Relationship between intensity of night shift work and antioxidant status in blood of nurses. Int Arch Occup Environ Health 2012 0.79
51 Rotating night shift work and polymorphism of genes important for the regulation of circadian rhythm. Scand J Work Environ Health 2012 0.79
52 Simultaneous analysis of five genetic risk factors in Polish patients with Alzheimer's disease. Neurosci Lett 2003 0.78
53 Circadian gene expression in peripheral blood leukocytes of rotating night shift nurses. Scand J Work Environ Health 2012 0.77
54 Prolactin receptor expression and breast cancer: relationships with tumor characteristics among pre- and post-menopausal women in a population-based case-control study from Poland. Horm Cancer 2013 0.77
55 Analysis of APBB2 gene polymorphisms in sporadic Alzheimer's disease. Neurosci Lett 2008 0.76
56 Urinary bisphenol A-glucuronide and postmenopausal breast cancer in Poland. Cancer Causes Control 2014 0.76
57 Fine mapping of 14q24.1 breast cancer susceptibility locus. Hum Genet 2011 0.75
58 Rotating night shift work, sleep quality, selected lifestyle factors and prolactin concentration in nurses and midwives. Chronobiol Int 2014 0.75